Literature DB >> 20027687

High expression of osteoglycin decreases gelatinase activity of murine hepatocarcinoma Hca-F cells.

Xiao-Nan Cui1, Jian-Wu Tang, Bo Song, Bo Wang, Shan-Yan Chen, Li Hou.   

Abstract

AIM: To investigate the possible correlation between osteoglycin expression and gelatinase activity of mouse hepatocarcinoma Hca-F cells.
METHODS: A eukaryotic expression plasmid pIRESpuro3 osteoglycin(+) was constructed and transfected into Hca-F cells to investigate the possible correlation between osteoglycin expression and gelatinase activity of Hca-F cells cultured with extract of lymph node, liver, spleen or in DMEM medium. The activity of gelatinases was examined through zymographic analysis.
RESULTS: High expression of osteoglycin attenuated the gelatinase activity of Hca-F cells cultured with extract of lymph node, and at the same time, decreased the metastatic potential of Hca-F cells to peripheral lymph nodes in vivo.
CONCLUSION: High expression of osteoglycin decreases the gelatinase activity of Hca-F cells cultured with extract of lymph node; regulation of gelatinase activity might be one of mechanisms that osteoglycin contributes to lymphatic metastasis suppression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20027687      PMCID: PMC2797671          DOI: 10.3748/wjg.15.6117

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  Proteoglycans of the extracellular matrix and growth control.

Authors:  H Kresse; E Schönherr
Journal:  J Cell Physiol       Date:  2001-12       Impact factor: 6.384

2.  Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities.

Authors:  Elena S Tasheva; Anja Koester; Avelina Q Paulsen; Alexander S Garrett; Dan L Boyle; Harriet J Davidson; Min Song; Niles Fox; Gary W Conrad
Journal:  Mol Vis       Date:  2002-10-31       Impact factor: 2.367

3.  Tumour necrosis factor-alpha interacts with biglycan and decorin.

Authors:  Ellen Tufvesson; Gunilla Westergren-Thorsson
Journal:  FEBS Lett       Date:  2002-10-23       Impact factor: 4.124

4.  Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy.

Authors:  A H Plaas; L A West; E J Thonar; Z A Karcioglu; C J Smith; G K Klintworth; V C Hascall
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

5.  Analysis of the promoter region of human mimecan gene.

Authors:  Elena S Tasheva
Journal:  Biochim Biophys Acta       Date:  2002-05-03

6.  Interferon-gamma regulation of the human mimecan promoter.

Authors:  Elena S Tasheva; Gary W Conrad
Journal:  Mol Vis       Date:  2003-06-30       Impact factor: 2.367

7.  Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis.

Authors:  Gaoxiang Ge; Neung-Seon Seo; Xiaowen Liang; Delana R Hopkins; Magnus Höök; Daniel S Greenspan
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

Review 8.  The tumor microenvironment and metastatic disease.

Authors:  Sarah Jane Lunt; Naz Chaudary; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

Review 9.  Macrophages define the invasive microenvironment in breast cancer.

Authors:  Jeffrey W Pollard
Journal:  J Leukoc Biol       Date:  2008-05-08       Impact factor: 4.962

Review 10.  Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases.

Authors:  Laurent Ameye; Marian F Young
Journal:  Glycobiology       Date:  2002-09       Impact factor: 4.313

View more
  5 in total

1.  Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery.

Authors:  Harsh Pawar; Manoj Kumar Kashyap; Nandini A Sahasrabuddhe; Santosh Renuse; H C Harsha; Praveen Kumar; Jyoti Sharma; Kumaran Kandasamy; Arivusudar Marimuthu; Bipin Nair; Sudha Rajagopalan; Jagadeesha Maharudraiah; Chennagiri Shrinivasamurthy Premalatha; Kariyanakatte Veeraiah Veerendra Kumar; M Vijayakumar; Raghothama Chaerkady; Thotterthodi Subrahmanya Keshava Prasad; Rekha V Kumar; Rekha V Kumar; Akhilesh Pandey
Journal:  Cancer Biol Ther       Date:  2011-09-15       Impact factor: 4.742

2.  Role of osteoglycin in the linkage between muscle and bone.

Authors:  Ken-ichiro Tanaka; Erika Matsumoto; Yoshiko Higashimaki; Takenobu Katagiri; Toshitsugu Sugimoto; Susumu Seino; Hiroshi Kaji
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

3.  Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics.

Authors:  C Y X'avia Chan; John C McDermott; K W Michael Siu
Journal:  Int J Proteomics       Date:  2011-03-29

4.  Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.

Authors:  Filip Mundt; Henrik J Johansson; Jenny Forshed; Sertaç Arslan; Muzaffer Metintas; Katalin Dobra; Janne Lehtiö; Anders Hjerpe
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

5.  Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.

Authors:  Tao Xu; Rui Zhang; Menglu Dong; Zeyu Zhang; Hanning Li; Chenao Zhan; Xingrui Li
Journal:  Onco Targets Ther       Date:  2019-12-04       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.